JESSICA SURLOFF: Open Payments
NPI 1609044957 · SPRINGFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 30 payments from 15 companies in 2025. Trend: 2023 $1,256 · 2024 $1,151 · 2025 $725
Food & beverage: $646Education: $79
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 5 | $212 |
| Daiichi Sankyo Inc. | 5 | $137 |
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| ABBVIE INC. | 4 | $67 |
| Janssen Biotech, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| TAIHO ONCOLOGY, INC. | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| Rigel Pharmaceuticals, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: CABOMETYX, Enhertu, DATROWAY, TALVEY, SCEMBLIX, IMBRUVICA, FRUZAQLA, LONSURF.
Industry payments across NJ — which companies pay providers there.
